Common Allergy Drug Linked to Suicide

Asthma and allergy drug montelukast – sold as a generic and under the brand name Singulair – will get a “boxed warning” over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced on Wednesday.